Millennium Management’s Immunomedics Inc IMMU Stock Holding History

Millennium Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-372,600	Closed	-$31.7K	–	5850
2020 Q3	$31.7K	Buy	372,600 +352,600	+1,763%	+$17.8M	0.04%	523
2020 Q2	$709K	Hold	20,000	–	–	﹤0.01%	3197
2020 Q1	$270K	Hold	20,000	–	–	﹤0.01%	3241
2019 Q4	$423K	Buy	+20,000	New	+$353K	﹤0.01%	3485
2019 Q2	–	Sell	-50,000	Closed	-$961K	–	4684
2019 Q1	$961K	Buy	+50,000	New	+$806K	﹤0.01%	2890
2018 Q2	–	Sell	-62,600	Closed	-$915K	–	4352
2018 Q1	$915K	Sell	62,600 -37,400	-37%	-$611K	﹤0.01%	2737
2017 Q4	$1.62M	Hold	100,000	–	–	﹤0.01%	2411
2017 Q3	$1.4M	Buy	+100,000	New	+$997K	﹤0.01%	2347

Millennium Management's IMMU Position: Q4 2020 in Review

Millennium Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 2,750,749 shares — an estimated $234K sold.

Millennium Management first reported a position in IMMU in Q2 2013 and held it in 24 quarters. The position peaked at $102M in Q4 2017. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Millennium Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Millennium Management sold 2,750,749 Immunomedics Inc shares in Q4 2020, an estimated $234K.
Millennium Management first reported a position in Immunomedics Inc in Q2 2013 and held it in 24 quarters.
Millennium Management's Immunomedics Inc position peaked at $102M in Q4 2017.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Millennium Management's 13F filing for Q4 2020, filed 16 Feb 2021.